Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
About this item
Full title
Author / Creator
Shan, Enfang , Cao, Yi-nan , Zhang, Yang , Chen, Wen , Ren, Xurui , Zhu, Shanjie , Xi, Xueru , Mu, Shuai , Ma, Mian , Zhi, Tongle and Li, Xianwen
Publisher
London: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Gliomas are the most common malignant primary brain tumors in adults with poor prognoses. The purpose of this study is to explore CACNG3 as a prognostic factor that is closely related to the progression and survival outcome of gliomas and to provide a potential new molecular target for the diagnosis and treatment of glioma patients. CACNG3 expressi...
Alternative Titles
Full title
Integrated profiling identifies CACNG3 as a prognostic biomarker for patients with glioma
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_190fb14a0aa742aa89fee6ea077e8300
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_190fb14a0aa742aa89fee6ea077e8300
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-023-10896-1
